David Lee Johnson, Chief Operating Officer of Vera Therapeutics, Inc. ($VERA), sold shares on the open market once in the last 365 days for a total of $108 thousand. His most recent sale occurred on February 23, 2026. These sales rank 9,452nd among 11,678 individual insiders, where the average is $8.6 million across about six transactions. Johnson made no open market purchases during this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 23, 2026 | Vera Therapeutics, Inc. | $VERA | JOHNSON DAVID LEE | Chief Operating Officer | S | Class A Common Stock | 2579 | $41.98 | 45,727.0000 | 63,928,066 | 5.34% | 0.00% |
| Feb. 20, 2026 | Caribou Biosciences, Inc. | $CRBU | JOHNSON DAVID LEE | Director | A | Option to purchase Common Stock | 45000 | $0.00 | 45,000.0000 | 93,468,038 | 9999.99% | 0.05% |
| Feb. 4, 2026 | Vera Therapeutics, Inc. | $VERA | JOHNSON DAVID LEE | Chief Operating Officer | A | Class A Common Stock | 20000 | $0.00 | 48,306.0000 | 63,928,066 | 70.66% | 0.03% |
| Feb. 4, 2026 | Vera Therapeutics, Inc. | $VERA | JOHNSON DAVID LEE | Chief Operating Officer | A | Stock Option (right to buy) | 40000 | $0.00 | 40,000.0000 | 63,928,066 | 9999.99% | 0.06% |
| Feb. 20, 2025 | Caribou Biosciences, Inc. | $CRBU | JOHNSON DAVID LEE | Director | A | Option to purchase Common Stock | 40500 | $0.00 | 40,500.0000 | 0 | 9999.99% | 0.00% |
| Feb. 18, 2025 | Vera Therapeutics, Inc. | $VERA | JOHNSON DAVID LEE | Chief Operating Officer | A | Stock Option (right to buy) | 53800 | $0.00 | 53,800.0000 | 0 | 9999.99% | 0.00% |
| Feb. 18, 2025 | Vera Therapeutics, Inc. | $VERA | JOHNSON DAVID LEE | Chief Operating Officer | A | Class A Common Stock | 26900 | $0.00 | 26,900.0000 | 0 | 9999.99% | 0.00% |
| July 1, 2024 | Vera Therapeutics, Inc. | $VERA | JOHNSON DAVID LEE | Chief Operating Officer | A | Stock Option (right to buy) | 160000 | $0.00 | 160,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 20, 2024 | Caribou Biosciences, Inc. | $CRBU | JOHNSON DAVID LEE | Director | A | Option to purchase Common Stock | 39500 | $0.00 | 39,500.0000 | 0 | 9999.99% | 0.00% |